Aegerion Pharmaceuticals, Inc.
CIK 0001338042
Revenue (TTM)
—
Q3 Oct 2016
Net Income (TTM)
−$148.69M
−274.8% YoY
Q3 Oct 2016
EPS Diluted (TTM)
—
Q3 Oct 2016
Gross Margin
—
Q3 Oct 2016
Operating Margin
—
Q3 Oct 2016
Net Margin
—
Q3 Oct 2016
Free Cash Flow (TTM)
−$39.99M
Q3 Oct 2016
Cash
$32.36M
Q3 Oct 2016
Total Debt
$27.92M
Q3 Oct 2016
Shares Outstanding
29.55M sh
Q3 Oct 2016
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.